2025年全球液态切片市场报告

预计未来几年液态切片的市场规模将快速成长。到 2029 年，这一数字将成长至 27.6 亿美元，复合年增长率为 17.2%。预测期内的成长将归因于应用范围的扩大、癌症监测、新兴技术、伴随诊断和生物标记的发现。预测期内的关键趋势包括癌症检测和监测、治疗监测、微小残留疾病 (MRD) 监测以及非癌症应用中的液态切片。

政府增加对癌症检测进步的资助是推动液态切片市场成长的主要因素。这笔资金主要来自全球癌症负担的增加、早期发现以改善治疗效果的需求，以及透过创新诊断技术降低医疗成本的重视。政府的支持将透过加速研究、资助临床试验和推广使用先进的非侵入性诊断方法进行早期癌症检测和个人化治疗方法来帮助液态切片的发展。例如，2024 年 10 月，英国政府网站 gov.UK 报告称，已拨款 1.18 亿英镑（1.5038 亿美元）用于英国的研究和创新。因此，政府对癌症检测进步的资助增加正在推动液态切片市场的成长。

预计癌症发生率的上升将推动液态切片市场的扩张。癌症的特征是细胞增殖不受控制且具有侵袭性，可以透过液态切片技术检测出来。这些技术可以识别患者血液样本中的癌症特异性生物标记物，例如循环肿瘤DNA（ctDNA）和循环性肿瘤细胞（CTC），从而实现非侵入性诊断和监测。例如，美国癌症协会预测，美国新诊断的癌症病例将从 2022 年的 1,918,030 多例增加到 2023 年的 1,958,310 例。癌症发生率的快速成长正在推动液态切片市场的成长。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、新冠疫情、经济復苏对市场的影响

第五章 全球成长分析与策略分析框架

• 全球液态切片PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
• 最终用途产业分析
• 全球液态切片市场：成长率分析
• 全球液态切片市场表现：规模与成长，2019-2024
• 全球液态切片市场预测：规模与成长，2024-2029，2034
• 全球液态切片总目标市场（TAM）

第六章市场区隔

• 全球液态切片市场（依产品、绩效及预测），2019-2024 年、2024-2029 年、2034 年
• 检测试剂套件
• 装置
• 服务
• 全球液态切片市场（依临床应用）表现及预测（2019-2024、2024-2029、2034）
• 早期癌症筛检
• 治疗方法方案
• 治疗监测
• 復发监测整形外科
• 全球液态切片市场（按最终用户、绩效及预测），2019-2024 年、2024-2029 年、2034 年
• 参考实验室
• 医院和医生检查室
• 学术研究中心
• 全球液态切片市场，按检测试剂套件类型细分，性能和预测，2019-2024 年、2024-2029 年、2034 年
• cfDNA检测
• ctDNA检测
• 基于外泌体的检测
• 基于RNA的检测
• 基于蛋白质的检测
• 全球液态切片市场，按设备类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
• PCR设备
• 次世代定序（NGS）仪器
• 微阵列仪器
• 质谱仪
• 全球液态切片市场，按服务类型、绩效和预测细分，2019-2024 年、2024-2029 年、2034 年
• 测试服务
• 数据分析服务
• 化验服务
• 客製化检测开发服务

第七章 区域和国家分析

• 全球液态切片市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 全球液态切片市场：依国家、表现及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

• 液态切片市场：竞争格局
• 液态切片市场：公司简介
  • QIAGEN NV Overview, Products and Services, Strategy and Financial Analysis
  • Roche Diagnostics Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Myriad Genetics Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Guardant Health Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

• Thermo Fisher Scientific Inc.
• Menarini Silicon Biosystems
• Biocept Inc.
• Janssen Diagnostics LLC
• Trovagene Inc.
• Fraunhofer-Gesellschaft
• MDX Health SA
• Agilent Technologies Inc.
• Illumina Inc.
• Oxford Nanopore Technologies Ltd.
• Quantum Biosystems Inc.
• Menarini Silicon Biosystems Inc.
• Pathway Genomics Corporation
• Sysmex Corporation
• Janssen Global Services LLC

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

• 2029年液态切片市场：提供新机会的国家
• 2029年液态切片市场：细分领域带来新机会
• 2029年液态切片市场：成长策略
  • 基于市场趋势的策略
  • 竞争对手的策略

第36章 附录

A liquid biopsy is a non-invasive and relatively painless alternative to surgical biopsies, enabling healthcare professionals to obtain valuable information about tumors through a simple blood sample. It is a diagnostic test conducted on blood to identify the presence of cancerous cells, often used for early-stage cancer detection.

The primary product types within the liquid biopsy market encompass assay kits, instruments, and services. Assay kits provide the necessary reagents and components for conducting analytical tests, which are used in various industries such as food, cereals and dietary fiber, dairy, analytical laboratories, animal feed and nutrition, biofuels, biotechnology, wine, malting and brewing, and research. Liquid biopsy has numerous clinical applications, including early cancer screening, therapy selection, treatment monitoring, and recurrence monitoring, which are utilized by reference laboratories, hospitals and physician laboratories, and academic and research centers in the field of orthopedics and oncology, among others.

The liquid biopsy market research report is one of a series of new reports from The Business Research Company that provides liquid biopsy market statistics, including liquid biopsy industry, regional shares, competitors with a liquid biopsy market share, detailed liquid biopsy market segments, market trends and opportunities, and any further data you may need to thrive in the liquid biopsy industry. This liquid biopsy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The liquid biopsy market size has grown rapidly in recent years. It will grow from $1.25 billion in 2024 to $1.46 billion in 2025 at a compound annual growth rate (CAGR) of 16.4%. The growth in the historic period can be attributed to advances in cancer research, non-invasiveness, personalized medicine, regulatory approvals, early cancer detection.

The liquid biopsy market size is expected to see rapid growth in the next few years. It will grow to $2.76 billion in 2029 at a compound annual growth rate (CAGR) of 17.2%. The growth in the forecast period can be attributed to expanding applications, cancer monitoring, emerging technologies, companion diagnostics, biomarker discovery. Major trends in the forecast period include cancer detection and monitoring, therapeutic monitoring, minimal residual disease (mrd) monitoring, liquid biopsy in non-oncological applications.

The rise in government funding for cancer detection advancements is a major factor driving the growth of the liquid biopsy market. This funding is largely due to the increasing global cancer burden, the need for early detection to improve treatment outcomes, and the emphasis on reducing healthcare costs through innovative diagnostic technologies. Government support aids liquid biopsy development by accelerating research, funding clinical trials, and promoting the use of advanced, non-invasive diagnostic methods for early cancer detection and personalized treatment approaches. For example, in October 2024, gov.UK, a UK-based government website, reported that £118 million ($150.38 million) was allocated to UK Research and Innovation, including £54 million from the government and £64 million ($81.55 million) from partners. Therefore, the rise in government funding for cancer detection advancements is propelling the growth of the liquid biopsy market.

The rising incidence of cancer is expected to drive the expansion of the liquid biopsy market. Cancer, characterized by uncontrolled cell growth and invasive tendencies, is detectable through liquid biopsy methods. These techniques identify cancer-specific biomarkers like circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs) in a patient's blood sample, enabling non-invasive diagnosis and monitoring. For instance, the American Cancer Society Inc. projects an increase in newly diagnosed cancer cases in the USA, from over 1,918,030 cases in 2022 to an estimated 1,958,310 cases in 2023. This surge in cancer prevalence serves as a driver for the liquid biopsy market's growth.

Businesses are rapidly adapting to new market demands and are notably prioritizing the launch of cutting-edge products within the liquid biopsy sector. This initiative aims to address the ever-increasing requirement for liquid biopsy products and services, augmenting their revenue and establishing a competitive advantage over their competitors. As an example, in June 2023, Laboratory Corporation of America Holdings, a US-based healthcare company, introduced Labcorp Plasma Focus, a liquid biopsy test engineered for identifying cancer-associated biomarkers in individuals with advanced or metastatic solid tumors. The test leverages the analysis of cell-free DNA (cfDNA) present in a patient's blood sample, constructing a detailed genomic profile of their tumor. This approach equips oncologists to refine patient healthcare management by creating personalized and precisely targeted therapy strategies.

Prominent companies involved in the liquid biopsy market are dedicating their efforts to the development of extensive liquid biopsy panels to gain a competitive edge. These extensive liquid biopsy panels serve as advanced diagnostic tools, analyzing various biomarkers within a patient's blood sample to detect and monitor a wide array of diseases, notably cancer. For instance, in June 2022, Tempus Labs Inc., a US-based technology company focused on precision medicine through artificial intelligence, announced the introduction of xF+, the most expansive liquid biopsy panel clinically available. This panel covers a broader range of genes, including single nucleotide variants, indels in all genes, and an expanded coverage of translocations, gene rearrangements, and copy number variants. Additionally, the xF+ panel evaluates blood-based tumor mutational burden (bTMB) and microsatellite instability, providing essential predictive biomarkers for various cancer immunotherapies' efficacy.

In February 2024, Veracyte Inc., a US-based diagnostics company, acquired C2i Genomics Inc. for $70 million. Through this acquisition, Veracyte aims to enhance its diagnostics platform by integrating whole-genome minimal residual disease (MRD) capabilities. This deal allows Veracyte to leverage C2i's AI-driven technology to improve the detection of circulating tumor DNA from blood samples, with the goal of expanding its cancer care offerings. C2i Genomics Inc., also based in the US, specializes in AI-powered liquid biopsy for cancer diagnostics.

Major companies operating in the liquid biopsy market include QIAGEN NV, Roche Diagnostics Ltd., Bio-Rad Laboratories Inc., Myriad Genetics Inc., Guardant Health Inc., Thermo Fisher Scientific Inc., Menarini Silicon Biosystems, Biocept Inc., Janssen Diagnostics LLC, Trovagene Inc., Fraunhofer-Gesellschaft, MDX Health SA, Agilent Technologies Inc., Illumina Inc., Oxford Nanopore Technologies Ltd., Quantum Biosystems Inc., Menarini Silicon Biosystems Inc., Pathway Genomics Corporation, Sysmex Corporation, Janssen Global Services LLC, Natera Inc., ANGLE PLC, Bio Techne Corp, Biodesix Inc., CellMax Inc., CIRCULOGENE, Exact Sciences Corporation, Epic Sciences Inc., Exosome Diagnostics Inc., GRAIL Inc., Guardant Health AMEA, Inivata Ltd., NIPD Genetics, Oncocyte Corporation, Personal Genome Diagnostics Inc., RainDance Technologies Inc., Thrive Earlier Detection Corp.

North America was the largest region in the liquid biopsy market in 2024. Western Europe was the second largest region in the liquid biopsy market. The regions covered in the liquid biopsy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the liquid biopsy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

The liquid biopsy market includes revenues earned by entities by DNA collection tubes, tests, and reagents. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Liquid Biopsy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on liquid biopsy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for liquid biopsy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The liquid biopsy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Assays Kits; Instruments; Services
• 2) By Clinical Application: Early Cancer Screening; Therapy Selection; Treatment Monitoring; Recurrence Monitoring Orthopedics
• 3) By End User: Reference Laboratories; Hospitals and Physician Laboratories; Academic and Research Centers
• Subsegments:
• 1) By Assays Kits: cfDNA Assays; ctDNA Assays; Exosome-based Assays; RNA-based Assays; Protein-based Assays
• 2) By Instruments: PCR Instruments; Next-Generation Sequencing (NGS) Instruments; Microarray Instruments; Mass Spectrometry Instruments
• 3) By Services: Testing Services; Data Analysis Services; Laboratory Services; Custom Assay Development Services
• Companies Mentioned: QIAGEN NV; Roche Diagnostics Ltd.; Bio-Rad Laboratories Inc.; Myriad Genetics Inc.; Guardant Health Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Liquid Biopsy Market Characteristics

3. Liquid Biopsy Market Trends And Strategies

4. Liquid Biopsy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Liquid Biopsy Growth Analysis And Strategic Analysis Framework

• 5.1. Global Liquid Biopsy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Liquid Biopsy Market Growth Rate Analysis
• 5.4. Global Liquid Biopsy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Liquid Biopsy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Liquid Biopsy Total Addressable Market (TAM)

6. Liquid Biopsy Market Segmentation

• 6.1. Global Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Assays Kits
• Instruments
• Services
• 6.2. Global Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Early Cancer Screening
• Therapy Selection
• Treatment Monitoring
• Recurrence Monitoring Orthopedics
• 6.3. Global Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Reference Laboratories
• Hospitals and Physician Laboratories
• Academic and Research Centers
• 6.4. Global Liquid Biopsy Market, Sub-Segmentation Of Assays Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• cfDNA Assays
• ctDNA Assays
• Exosome-based Assays
• RNA-based Assays
• Protein-based Assays
• 6.5. Global Liquid Biopsy Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• PCR Instruments
• Next-Generation Sequencing (NGS) Instruments
• Microarray Instruments
• Mass Spectrometry Instruments
• 6.6. Global Liquid Biopsy Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Testing Services
• Data Analysis Services
• Laboratory Services
• Custom Assay Development Services

7. Liquid Biopsy Market Regional And Country Analysis

• 7.1. Global Liquid Biopsy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Liquid Biopsy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Liquid Biopsy Market

• 8.1. Asia-Pacific Liquid Biopsy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Liquid Biopsy Market

• 9.1. China Liquid Biopsy Market Overview
• 9.2. China Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Liquid Biopsy Market

• 10.1. India Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Liquid Biopsy Market

• 11.1. Japan Liquid Biopsy Market Overview
• 11.2. Japan Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Liquid Biopsy Market

• 12.1. Australia Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Liquid Biopsy Market

• 13.1. Indonesia Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Liquid Biopsy Market

• 14.1. South Korea Liquid Biopsy Market Overview
• 14.2. South Korea Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Liquid Biopsy Market

• 15.1. Western Europe Liquid Biopsy Market Overview
• 15.2. Western Europe Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Liquid Biopsy Market

• 16.1. UK Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Liquid Biopsy Market

• 17.1. Germany Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Liquid Biopsy Market

• 18.1. France Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Liquid Biopsy Market

• 19.1. Italy Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Liquid Biopsy Market

• 20.1. Spain Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Liquid Biopsy Market

• 21.1. Eastern Europe Liquid Biopsy Market Overview
• 21.2. Eastern Europe Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Liquid Biopsy Market

• 22.1. Russia Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Liquid Biopsy Market

• 23.1. North America Liquid Biopsy Market Overview
• 23.2. North America Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Liquid Biopsy Market

• 24.1. USA Liquid Biopsy Market Overview
• 24.2. USA Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Liquid Biopsy Market

• 25.1. Canada Liquid Biopsy Market Overview
• 25.2. Canada Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Liquid Biopsy Market

• 26.1. South America Liquid Biopsy Market Overview
• 26.2. South America Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Liquid Biopsy Market

• 27.1. Brazil Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Liquid Biopsy Market

• 28.1. Middle East Liquid Biopsy Market Overview
• 28.2. Middle East Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Liquid Biopsy Market

• 29.1. Africa Liquid Biopsy Market Overview
• 29.2. Africa Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Liquid Biopsy Market Competitive Landscape And Company Profiles

• 30.1. Liquid Biopsy Market Competitive Landscape
• 30.2. Liquid Biopsy Market Company Profiles
  • 30.2.1. QIAGEN NV Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Roche Diagnostics Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Myriad Genetics Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Guardant Health Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Liquid Biopsy Market Other Major And Innovative Companies

• 31.1. Thermo Fisher Scientific Inc.
• 31.2. Menarini Silicon Biosystems
• 31.3. Biocept Inc.
• 31.4. Janssen Diagnostics LLC
• 31.5. Trovagene Inc.
• 31.6. Fraunhofer-Gesellschaft
• 31.7. MDX Health SA
• 31.8. Agilent Technologies Inc.
• 31.9. Illumina Inc.
• 31.10. Oxford Nanopore Technologies Ltd.
• 31.11. Quantum Biosystems Inc.
• 31.12. Menarini Silicon Biosystems Inc.
• 31.13. Pathway Genomics Corporation
• 31.14. Sysmex Corporation
• 31.15. Janssen Global Services LLC

32. Global Liquid Biopsy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Liquid Biopsy Market

34. Recent Developments In The Liquid Biopsy Market

35. Liquid Biopsy Market High Potential Countries, Segments and Strategies

• 35.1 Liquid Biopsy Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Liquid Biopsy Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Liquid Biopsy Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer